Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 391-408

  Aubert, Martine ^a   Krantz, Elizabeth M ^b   Jerome, Keith R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHROMIUM 51; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT GAMMA INTERFERON; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME ACTIVITY; FIBROBLAST; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; TARGET CELL; US12 GENE; US3 GENE; US5 GENE; VERO CELL; VIRUS GENE; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; FLOW CYTOMETRY; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES, CYTOTOXIC; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 33750946811     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.391     Document Type: Conference Paper

References (61)

1. + cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. U.S.A. 1997;94:10289-10294.
2. Cunningham AL, Turner RR, Miller AC, Para MF, and Merigan TC: Evolution of recurrent herpes simplex lesions: An immunohistologic study. J. Clin. Invest. 1985;75:226-233.
3. Koelle DM, Posavad CM, Barnum GR, Johnson ML, Frank JM, and Corey L: Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 1998;101:1500-1508.
4. Wald A, Zeh J, Selke S, Ashley RL, and Corey L: Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 1995;333:770-775.
5. Roizman B, and Sears AE: Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, and Howley PM (eds.), Fields Virology, 3rd ed., Vol. 2, p. 2231. Lippincott-Raven, Philadelphia, 1996.
6. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, and Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 1995;375:415-418.
7. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, and Johnson D: Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-415.
8. Kwong AD, and Frenkel N: The herpes simplex virus virion host shutoff function. J. Virol. 1989;63:4834-4839.
9. Boehm U, Klamp T, Groot M, and Howard JC: Cellular responses to interferon-γ. Annu. Rev. Immunol. 1997;15:749-795.
10. Torseth JW, and Merigan TC: Significance of local γ interferon in recurrent herpes simplex infection. J. Infect. Dis. 1986;153:979-984.
11. L41 genes of herpes simplex virus 1. J. Virol. 2002;76:6974-6986.
12. Berke G: The CTL's kiss of death. Cell 1995;81:9-12.
13. Darmon AJ, Ley TJ, Nicholson DW, and Bleackley RC: Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J. Biol. Chem. 1996;271:21709-21712.
14. Golstein P: Fas-based T cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 1995;198:25-37.
15. Podack ER: Perform, killer cells and gene transfer immunotherapy for cancer. Curr. Top. Microbiol. Immunol. 1995;198:121-130.
16. Shresta S, Pham CT, Thomas DA, Graubert TA, and Ley TJ: How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 1998;10:581-587.
17. Trapani JA, Davis J, Sutton VR, and Smyth MJ: Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr. Opin. Immunol. 2000;12:323-329.
18. Aubert M, and Blaho JA: The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J. Virol. 1999;73:2803-2813.
19. Aubert M, O'Toole J, and Blaho JA: Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J. Virol. 1999;73:10359-10370.
20. Galvan V, and Roizman B: Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 1998;95:3931-3936.
21. Jerome KR, Fox R, Chen Z, Sears AE, Lee H, and Corey L: Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 1999;73:8950-8957.
22. Jerome KR, Tait JF, Koelle DM, and Corey L: Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 1998;72:436-441.
23. Koyama AH, and Miwa Y: Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 1997;71:2567-2571.
24. Jerome KR, Chen Z, Lang R, Torres MR, Hofmeister J, Smith S, Fox R, Froelich CJ, and Corey L: HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J. Immunol. 2001;167:3928-3935.
25. Leopardi R, Van Sant C, and Roizman B: The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. U.S.A. 1997;94:7891-7896.
26. Zhou G, Galvan V, Campadelli-Fiume G, and Roizman B: Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J. Virol. 2000;74:11782-11791.
27. + cytotoxic T lymphocytes. J. Clin. Invest. 1993;91:961-968.
28. Posavad CM, and Rosenthal KL: Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J. Virol. 1992;66:6264-6272.
29. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL, Shabanowitz J, Eisenlohr LC, Hunt DF, Engelhard VH, and Riddell SR: The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J. Exp. Med. 2001;193:195-206.
30. Purves FC, Longnecker RM, Leader DP, and Roizman B: Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J. Virol. 1987;61:2896-2901.
31. + T cell response. J. Exp. Med. 1998;187:341-348.
32. Jerome KR, Sloan DD, and Aubert M: Measurement of CTL-induced cytotoxicity. the caspase 3 assay. Apoptosis 2003;8:563-571.
33. Jerome KR, Sloan DD, and Aubert M: Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3. Nat. Med. 2003;9:4-5.
34. +-ATPase, on CTL-mediated cytotoxicity. J. Immunol. 1994;153:3938-3947.
35. Martz E, and Gamble SR: How do CTL control virus infections? Evidence for prelytic halt of herpes simplex. Viral Immunol. 1992;5:81-91.
36. + cytotoxic T lymphocytes. J. Virol. 2000;74:4465-4473.
37. + T lymphocytes. Cell 1994;77:525-535.
38. Mikloska Z, Kesson AM, Penfold ME, and Cunningham AL: Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ. J. Infect. Dis. 1996;173:7-17.
39. + CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled. J. Immunol. 1996;156:3901-3910.
40. Leib DA: Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immunol. 2002;269:171-185.
41. Aubert M, and Blaho JA: Modulation of apoptosis during herpes simplex virus infection in human cells. Microbes Infeet. 2001;3:859-866.
42. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, and Henkart PA: Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 1997;6:209-215.
43. Aubert M, Rice SA, and Blaho JA: Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J. Virol. 2001;75:1013-1030.
44. Benetti L, and Roizman B: Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2004;101:9411-9416.
45. Cartier A, Komai T, and Masucci NG: The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad. Exp. Cell Res. 2003;291:242-250.
46. Munger J, and Roizman B: The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. U.S.A. 2001;98:10410-10415.
47. Ogg PD, McDonell PJ, Ryckman BJ, Knudson CM, and Roller RJ: The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 2004;319:212-224.
48. Cartier A, Broberg E, Komai T, Henriksson M, and Masucci MG: The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B. Cell Death Differ. 2003;10:1320-1328.
49. Sloan DD, Han JY, Sandifer TK, Stewart M, Hinz AJ, Yoon M, Johnson DC, Spear PG, and Jerome KR: Inhibition of T cell receptor signaling by herpes simplex virus. J. Immunol. 2006;176:1825-1833.
50. Sloan DD, Zahariadis G, Posavad CM, Pate NT, Kussick SJ, and Jerome KR: CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J. Immunol. 2003;171:6733-6741.
51. Kagi D, Ledermann B, Burki K, Zinkernagel RM, and Hengartner H: Lymphocyte-mediated cytotoxicity in vitro and in vivo: Mechanisms and significance. Immunol. Rev. 1995;146:95-115.
52. Meignier B, Longnecker R, Mavromara-Nazos P, Sears AE, and Roizman B: Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 1988;162:251-254.
53. Yamamoto M, Kurachi R, Morishima T, Kito J, and Nishiyama Y: Immunohistochemical studies on the transneuronal spread of virulent herpes simplex virus type 2 and its US3 protein kinase-deficient mutant after ocular inoculation. Microbiol. Immunol. 1996;40:289-294.
54. Asano S, Honda T, Goshima F, Nishiyama Y, and Sugiura Y: US3 protein kinase of herpes simplex virus protects primary afferent neurons from virus-induced apoptosis in ICR mice. Neurosci. Lett. 2000;294:105-108.
55. Asano S, Honda T, Goshima F, Watanabe D, Miyake Y, Sugiura Y, and Nishiyama Y: US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J. Gen. Virol. 1999;80:51-56.
56. Reynolds AE, Wills EG, Roller RJ, Ryckman BJ, and Baines JD: Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids, J. Virol. 2002;76:8939-8952.
57. Howell DM, and Martz E: Intracellular reovirus survives cytotoxic T lymphocyte-mediated lysis of its host cell. J. Gen. Virol. 1987;68:2899-2907.
58. Pasquetto V, Wieland S, and Chisari FV: Intracellular hepatitis B virus nueleocapsids survive cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 2000;74:9792-9796.
59. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 2000;191:1459-1466.
60. Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, and Corey L: CD8 CTL from genital herpes simplex lesions: Recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 2001;166:4049-4058.
61. Wowk ME, and Trapani JA: Cytotoxic activity of the lymphocyte toxin granzyme B. Microbes Infect. 2004;6:752-758.